Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain.
Sluchanko NN, Shcheblyakov DV, Varfolomeeva LA, Favorskaya IA, Dolzhikova IV, Korobkova AI, Alekseeva IA, Esmagambetov IB, Derkaev AA, Prokofiev VV, Zorkov ID, Logunov DY, Gintsburg AL, Popov VO, Boyko KM. Sluchanko NN, et al. Among authors: alekseeva ia. Biochemistry (Mosc). 2024 Jul;89(7):1260-1272. doi: 10.1134/S0006297924070083. Biochemistry (Mosc). 2024. PMID: 39218023 Free article.
Broadly Reactive Nanobody Targeting the H3 Hemagglutinin of the Influenza A Virus.
Shcheblyakov DV, Voronina DV, Favorskaya IA, Esmagambetov IB, Alekseeva IA, Korobkova AI, Ryabova EI, Derkaev AA, Kan VY, Dzharullaeva AS, Tukhvatulin AI, Bandelyuk AS, Shmarov MM, Logunov DY, Gintsburg AL. Shcheblyakov DV, et al. Among authors: alekseeva ia. Acta Naturae. 2024 Jan-Mar;16(1):101-110. doi: 10.32607/actanaturae.27374. Acta Naturae. 2024. PMID: 38698957 Free PMC article.
Structural insight into recognition of Clostridioides difficile toxin A by novel neutralizing nanobodies targeting QTIN-like motifs within its receptor-binding domain.
Sluchanko NN, Sokolova IV, Favorskaya IA, Esmagambetov IB, Tukhvatulin AI, Alekseeva IA, Ungur AS, Varfolomeeva LA, Boyko KM, Logunov DY, Gintsburg AL, Popov VO, Shcheblyakov DV, Belyi YF. Sluchanko NN, et al. Among authors: alekseeva ia. Int J Biol Macromol. 2024 Dec;283(Pt 4):137910. doi: 10.1016/j.ijbiomac.2024.137910. Epub 2024 Nov 20. Int J Biol Macromol. 2024. PMID: 39577542
Retrospective Analysis of Lipid-Lowering and Antiplatelet Therapy Regimen by Clinical Decision Support Service Based on Real-World Data from Electronic Medical Records "Intellect 3 Study".
Benimetskaya KS, Provatorov SI, Ezhov MV, Krivosheev YS, Gavrilko AD, Uranov AE, Mikheenko IL, Kovalev EA, Ponomarenko AV, Shangina AM, Efremova YE, Kolmakova TE, Matveeva MA, Dolgusheva YA, Alekseeva IA, Osokina AK, Nozadze DN, Atyunina IV, Paleev FN, Meshkova MA, Sharapova YA, Losik DV. Benimetskaya KS, et al. Among authors: alekseeva ia. Kardiologiia. 2023 Dec 5;63(11):46-56. doi: 10.18087/cardio.2023.11.n2555. Kardiologiia. 2023. PMID: 38088112 English, Russian.
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.
Favorskaya IA, Shcheblyakov DV, Esmagambetov IB, Dolzhikova IV, Alekseeva IA, Korobkova AI, Voronina DV, Ryabova EI, Derkaev AA, Kovyrshina AV, Iliukhina AA, Botikov AG, Voronina OL, Egorova DA, Zubkova OV, Ryzhova NN, Aksenova EI, Kunda MS, Logunov DY, Naroditsky BS, Gintsburg AL. Favorskaya IA, et al. Among authors: alekseeva ia. Front Immunol. 2022 Feb 24;13:822159. doi: 10.3389/fimmu.2022.822159. eCollection 2022. Front Immunol. 2022. PMID: 35281053 Free PMC article.
81 results